202 related articles for article (PubMed ID: 28690324)
1. Proteasome inhibition suppresses Th17 cell generation and ameliorates autoimmune development in experimental Sjögren's syndrome.
Xiao F; Lin X; Tian J; Wang X; Chen Q; Rui K; Ma J; Wang S; Wang Q; Wang X; Liu D; Sun L; Lu L
Cell Mol Immunol; 2017 Jul; 14(11):924-34. PubMed ID: 28690324
[TBL] [Abstract][Full Text] [Related]
2. Th17 cells play a critical role in the development of experimental Sjögren's syndrome.
Lin X; Rui K; Deng J; Tian J; Wang X; Wang S; Ko KH; Jiao Z; Chan VS; Lau CS; Cao X; Lu L
Ann Rheum Dis; 2015 Jun; 74(6):1302-10. PubMed ID: 24573745
[TBL] [Abstract][Full Text] [Related]
3. Bufotalin ameliorates experimental Sjögren's syndrome development by inhibiting Th17 generation.
Huang Y; Yang G; Fei J; Wu Y; Yan J
Naunyn Schmiedebergs Arch Pharmacol; 2020 Oct; 393(10):1977-1985. PubMed ID: 31950221
[TBL] [Abstract][Full Text] [Related]
4. IL-10-producing regulatory B cells restrain the T follicular helper cell response in primary Sjögren's syndrome.
Lin X; Wang X; Xiao F; Ma K; Liu L; Wang X; Xu D; Wang F; Shi X; Liu D; Zhao Y; Lu L
Cell Mol Immunol; 2019 Dec; 16(12):921-931. PubMed ID: 30948793
[TBL] [Abstract][Full Text] [Related]
5. IL-17 drives salivary gland dysfunction via inhibiting TRPC1-mediated calcium movement in Sjögren's syndrome.
Xiao F; Du W; Zhu X; Tang Y; Liu L; Huang E; Deng C; Luo C; Han M; Chen P; Ding L; Hong X; Wu L; Jiang Q; Zou H; Liu D; Lu L
Clin Transl Immunology; 2021; 10(4):e1277. PubMed ID: 33968407
[TBL] [Abstract][Full Text] [Related]
6. Effect of the Chinese Herbal Medicine SS-1 on a Sjögren's Syndrome-Like Disease in Mice.
Wu PC; Lin SC; Panny L; Chang YK; Lin CC; Tung YT; Chang HH
Life (Basel); 2021 Jun; 11(6):. PubMed ID: 34200223
[TBL] [Abstract][Full Text] [Related]
7. Acteoside promotes B cell-derived IL-10 production and ameliorates autoimmunity.
Wu M; Yu S; Chen Y; Meng W; Chen H; He J; Shen J; Lin X
J Leukoc Biol; 2022 Oct; 112(4):875-885. PubMed ID: 35638582
[TBL] [Abstract][Full Text] [Related]
8. Olfactory ecto-mesenchymal stem cell-derived exosomes ameliorate murine Sjögren's syndrome by modulating the function of myeloid-derived suppressor cells.
Rui K; Hong Y; Zhu Q; Shi X; Xiao F; Fu H; Yin Q; Xing Y; Wu X; Kong X; Xu H; Tian J; Wang S; Lu L
Cell Mol Immunol; 2021 Feb; 18(2):440-451. PubMed ID: 33408339
[TBL] [Abstract][Full Text] [Related]
9. Metformin improves salivary gland inflammation and hypofunction in murine Sjögren's syndrome.
Kim JW; Kim SM; Park JS; Hwang SH; Choi J; Jung KA; Ryu JG; Lee SY; Kwok SK; Cho ML; Park SH
Arthritis Res Ther; 2019 Jun; 21(1):136. PubMed ID: 31164166
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cell transplantation ameliorates Sjögren's syndrome via suppressing IL-12 production by dendritic cells.
Shi B; Qi J; Yao G; Feng R; Zhang Z; Wang D; Chen C; Tang X; Lu L; Chen W; Sun L
Stem Cell Res Ther; 2018 Nov; 9(1):308. PubMed ID: 30409219
[TBL] [Abstract][Full Text] [Related]
11. Immunoproteasome subunit LMP7 deficiency and inhibition suppresses Th1 and Th17 but enhances regulatory T cell differentiation.
Kalim KW; Basler M; Kirk CJ; Groettrup M
J Immunol; 2012 Oct; 189(8):4182-93. PubMed ID: 22984077
[TBL] [Abstract][Full Text] [Related]
12. Labial gland-derived mesenchymal stem cells and their exosomes ameliorate murine Sjögren's syndrome by modulating the balance of Treg and Th17 cells.
Li B; Xing Y; Gan Y; He J; Hua H
Stem Cell Res Ther; 2021 Aug; 12(1):478. PubMed ID: 34446113
[TBL] [Abstract][Full Text] [Related]
13. Thrombospondin-derived peptide attenuates Sjögren's syndrome-associated ocular surface inflammation in mice.
Contreras Ruiz L; Mir FA; Turpie B; Masli S
Clin Exp Immunol; 2017 Apr; 188(1):86-95. PubMed ID: 28033649
[TBL] [Abstract][Full Text] [Related]
14. Stem cells from exfoliated deciduous teeth transplantation ameliorates Sjögren's syndrome by secreting soluble PD-L1.
Yang N; Liu X; Chen X; Yu S; Yang W; Liu Y
J Leukoc Biol; 2022 May; 111(5):1043-1055. PubMed ID: 34622984
[TBL] [Abstract][Full Text] [Related]
15. Aryl hydrocarbon receptor activation drives polymorphonuclear myeloid-derived suppressor cell response and efficiently attenuates experimental Sjögren's syndrome.
Wei Y; Peng N; Deng C; Zhao F; Tian J; Tang Y; Yu S; Chen Y; Xue Y; Xiao F; Zhou Y; Li X; Zou H; Rui K; Lin X; Lu L
Cell Mol Immunol; 2022 Dec; 19(12):1361-1372. PubMed ID: 36369368
[TBL] [Abstract][Full Text] [Related]
16. SLAMF3 promotes Th17 differentiation and is reversed by iguratimod through JAK1/STAT3 pathway in primary Sjögren's syndrome.
Hu P; Cai J; Yang C; Xu L; Ma S; Song H; Yang P
Int Immunopharmacol; 2024 Jan; 126():111282. PubMed ID: 38061117
[TBL] [Abstract][Full Text] [Related]
17. RORγt antagonist suppresses M3 muscarinic acetylcholine receptor-induced Sjögren's syndrome-like sialadenitis.
Tahara M; Tsuboi H; Segawa S; Asashima H; Iizuka-Koga M; Hirota T; Takahashi H; Kondo Y; Matsui M; Matsumoto I; Sumida T
Clin Exp Immunol; 2017 Feb; 187(2):213-224. PubMed ID: 27643385
[TBL] [Abstract][Full Text] [Related]
18. Extracellular vesicle-encapsulated miR-10a-5p derived from MDSCs restrains germinal center B cells in experimental Sjögren's syndrome.
Zhou H; Zhu Q; Mao Z; Li M; Zhang Y; Yang J; Ma J; Tian J; Wang S
Immunol Res; 2023 Oct; 71(5):760-770. PubMed ID: 37300798
[TBL] [Abstract][Full Text] [Related]
19. Impaired Interleukin-27-Mediated Control of CD4+ T Cell Function Impact on Ectopic Lymphoid Structure Formation in Patients With Sjögren's Syndrome.
Lucchesi D; Coleby R; Pontarini E; Prediletto E; Rivellese F; Hill DG; Derrac Soria A; Jones SA; Humphreys IR; Sutcliffe N; Tappuni AR; Pitzalis C; Jones GW; Bombardieri M
Arthritis Rheumatol; 2020 Sep; 72(9):1559-1570. PubMed ID: 32307922
[TBL] [Abstract][Full Text] [Related]
20. Tissue-specific up-regulation of the proteasome subunit beta5i (LMP7) in Sjögren's syndrome.
Egerer T; Martinez-Gamboa L; Dankof A; Stuhlmüller B; Dörner T; Krenn V; Egerer K; Rudolph PE; Burmester GR; Feist E
Arthritis Rheum; 2006 May; 54(5):1501-8. PubMed ID: 16646031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
